Anthem Blue Cross (HMO, PPO, EPO)
Onureg (azacitidine)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Lupus Nephritis:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Systemic Lupus Erythematosus (SLE):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Orally administered anticancer medication.
  • Anemia:
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Dialysis status: Patients on dialysis and not on dialysis
    Initial Therapy HgbHCT Requirements: Hgb < 10g/dL
    Initial Therapy Iron Stores Requirements: serum ferritin >= 100 ng/mL AND TSAT >= 20%
    Discontinuation requirements: No
    Reauthorization Requirements Iron Stores: serum ferritin >= 100 ng/mL AND TSAT >= 20%

    Anemia due to Chemotherapy:
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): 1 of Hematologist;Oncologist
    Reauthorization Required: No
    Duration of Reauthorization: <= 6 month(s)
    Initial Therapy HgbHCT Requirements: Hgb < 10g/dL
    Initial Therapy Iron Stores Requirements: serum ferritin >= 100 ng/mL AND TSAT >= 20%
    Diagnosis Types: concomitant myelosuppresive chemotherapy
    Dose Increase Requirements: No
    Discontinuation requirements: No
    Reauthorization Requirements HgbHCT: 2 of Hgb <= 10 g/dL;Must show response to therapy with increase in Hgb >= 1 g/dL
    Reauthorization Requirements Iron Stores: serum ferritin >= 100 ng/mL AND TSAT >= 20%

  • ST_APPLIES